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MEDIUM OPTIMIZATION CASE STUDY FOR CONTINUOUS UPSTREAM PROCESS
Rashmi Kshirsagar, Biogen
Rashmi.kshirsagar@biogen.com
Alan Gilbert, Biogen
Based on other mature industries, continuous upstream process is a logical replacement for current fed batch
operations. However most industrial medium development has focused on the biological requirements for fed
batch and therefore focused on the needs of stationary phase production. There is not an a priori expectation
that growth and stationary phase requirements are identical. Yet an ideal continuous upstream process requires
some combination of both. An optimal continuous upstream process requires a high cell density similar to fed
batch operations. There is also some minimum growth rate required in order to match the combined death and
cell removal rate at steady state. Hence, medium optimization yielding high productivity and sustaining sufficient
growth is critical. In our work, we first established the minimum metabolic requirements to exceed high cell
density at high viability based on our existing cell culture medium platform. Furthermore, the cells were able to
reach a high cell density within only a few days post inoculation. Optimization was still required in order to shift
from such a rapid growth process to a desirable high productivity continuous process. Fortunately, a continuous
system is an ideal setup within which to evaluate multiple effects sequentially. An individual component can be
spiked into the culture, and the direct impact can be monitored on cell growth and productivity. As the
continuous system will continually wash out the component, the individual component impact is temporal and
eventually the system returns to steady state in the absence of the spiked component. This process can be
repeated iteratively until an optimal result is obtained. In our case, multiple positive effects were combined into
one medium composition specifically optimized for a continuous upstream process.

